Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Mind Medicine Inc shares valued at $110,186 were sold by Sullivan Mark on Sep 25 ’25. At $9.77 per share, Sullivan Mark sold 11,278 shares. The insider’s holdings dropped to 293,852 shares worth approximately $3.39 million following the completion of this transaction.
Also, Barrow Robert sold 25,797 shares, netting a total of over 252,037 in proceeds. Following the sale of shares at $9.77 each, the insider now holds 804,268 shares.
Before that, Karlin Daniel had sold 7,704 shares from its account. In a trade valued at $75,268, the Chief Medical Officer traded Mind Medicine Inc shares for $9.77 each. Upon closing the transaction, the insider’s holdings decreased to 7,704 shares, worth approximately $4.97 million.
As published in their initiating research note from Needham on October 13, 2025, Mind Medicine Inc [MNMD] has been a Buy and the price target has been revised to $28. As of January 28, 2025, Evercore ISI has initiated its “an Outperform” rating for MNMD. Earlier on December 20, 2024, Chardan Capital Markets initiated its rating. Their recommendation was “a Buy” for MNMD stock.
Analyzing MNMD Stock Performance
On last trading session, Mind Medicine Inc [NASDAQ: MNMD] plunged -3.92% to $11.53. The stock’s lowest price that day was $11.41, but it reached a high of $12.0451 in the same session. During the last five days, there has been a drop of approximately -10.69%. Over the course of the year, Mind Medicine Inc shares have jumped approximately 87.79%. Shares of the company reached a 52-week high of $14.43 on 10/31/25 and a 52-week low of $4.70 on 04/09/25.
Support And Resistance Levels for Mind Medicine Inc (MNMD)
According to the 24-hour chart, there is a support level at 11.27, which, if violated, would cause prices to drop to 11.01. In the upper region, resistance lies at 11.92. The next price resistance is at 12.31. RSI (Relative Strength Index) is 44.71 on the 14-day chart, showing neutral technical sentiment.
Is Mind Medicine Inc subject to short interest?
Stocks of Mind Medicine Inc saw a sharp steep in short interest on 2025-10-15 dropping by -0.63 million shares to 10.06 million. Data from Yahoo Finance shows that the short interest on 2025-09-15 was 10.69 million shares. A decline of -6.25% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 5.27 of the overall float, the days-to-cover ratio (short ratio) decline to 5.27.
Which companies own the most shares of Mind Medicine Inc (MNMD)?
In terms of Mind Medicine Inc share price expectations, FactSet research, analysts set an average price target of 28 in the next 12 months, up nearly 133.33% from the previous closing price of $12.0. Analysts anticipate Mind Medicine Inc stock to reach 28 by 2025, with the lowest price target being 28. In spite of this, 2 analysts ranked Mind Medicine Inc stock as Buy at the end of 2025. On October 14, 2024, Leerink Partners assigned a price target of “an Outperform” to the stock and resumed coverage with a $20.
